The Patent Finder

Terms ending in 2033

Ipsen Biopharm Ltd.

Every in-force patent on Ipsen Biopharm Ltd.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,339,497Methods for Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
In force
 · High confidence
Ipsen Biopharm Ltd.In forceHigh confidence
US 9,364,473Methods for Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
In force
 · Medium confidence
Ipsen Biopharm Ltd.In forceMedium confidence
US 9,452,162Methods for Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
In force
 · Medium confidence
Ipsen Biopharm Ltd.In forceMedium confidence
US 9,492,442Methods for Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
In force
 · Medium confidence
Ipsen Biopharm Ltd.In forceMedium confidence
US 9,717,724Methods for Treating Pancreatic Cancer Using Combination Therapies
In force
 · Low confidence
Ipsen Biopharm Ltd.In forceLow confidence
US 10,980,795Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
In force
 · Medium confidence
Ipsen Biopharm Ltd.In forceMedium confidence
US 11,369,597Methods For Treating Pancreatic Cancer Using Combination Therapies
In force
 · Low confidence
Ipsen Biopharm Ltd.In forceLow confidence
US 10,030,238Recombinant Clostridium Botulinum Neurotoxins
In force
 · High confidence
Ipsen Bioinnovation Limited and Ipsen Biopharm LimitedIn forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited